Invention Grant
- Patent Title: Anti-ALK2 antibody
-
Application No.: US16543991Application Date: 2019-08-19
-
Publication No.: US11312776B2Publication Date: 2022-04-26
- Inventor: Takenobu Katagiri , Kenji Osawa , Sho Tsukamoto , Shinnosuke Tsuji , Yoshirou Kawaguchi , Kensuke Nakamura
- Applicant: Saitama Medical University , Daiichi Sankyo Company, Limited
- Applicant Address: JP Saitama; JP Tokyo
- Assignee: Saitama Medical University,Daiichi Sankyo Company, Limited
- Current Assignee: Saitama Medical University,Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Saitama; JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP2015-017882 20150130
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/28 ; A61P7/06 ; A61P19/08 ; A61P35/00 ; A61K45/06
Abstract:
This application provides: an antibody which specifically binds to an ALK2 protein and has an activity of inhibiting BMP signal transduction mediated by ALK2; a method for producing the antibody; and a pharmaceutical composition comprising the antibody, for treating and/or preventing ectopic ossification and/or bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).
Public/Granted literature
- US20200002427A1 ANTI-ALK2 ANTIBODY Public/Granted day:2020-01-02
Information query
